Clinical Trials · NCT00652379
Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Aarhus
- Enrollment
- 18
- Start date
- Jun 2008
- Locations
- 1 site, Denmark
- Primary endpoint
- Insulin sensitivity